BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 38618037)

  • 1. The current state of phage therapy in livestock and companion animals.
    Choi Y; Lee W; Kwon JG; Kang A; Kwak MJ; Eor JY; Kim Y
    J Anim Sci Technol; 2024 Jan; 66(1):57-78. PubMed ID: 38618037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage treatment as an alternative therapy for multidrug-resistant bacteria.
    Alqahtani A
    Saudi Med J; 2023 Dec; 44(12):1222-1231. PubMed ID: 38016738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
    Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
    Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
    Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Antibacterial Effect of Phage pB3074 in Combination with Antibiotics Targeting Cell Wall against Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Yang M; Liu M; Li Q; Wang P; Fan J; Jin J; Luo C
    Microbiol Spectr; 2023 Aug; 11(4):e0034123. PubMed ID: 37260382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Therapy in Livestock and Companion Animals.
    Ferriol-González C; Domingo-Calap P
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34064754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards promising antimicrobial alternatives: The future of bacteriophage research and development in Saudi Arabia.
    Alsaadi A; Imam M; Alghamdi AA; Alghoribi MF
    J Infect Public Health; 2022 Dec; 15(12):1355-1362. PubMed ID: 36332378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.
    Aranaga C; Pantoja LD; Martínez EA; Falco A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects and Challenges of Bacteriophage Substitution for Antibiotics in Livestock and Poultry Production.
    Jiang A; Liu Z; Lv X; Zhou C; Ran T; Tan Z
    Biology (Basel); 2024 Jan; 13(1):. PubMed ID: 38248459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage therapy for drug-resistant
    Liu K; Wang C; Zhou X; Guo X; Yang Y; Liu W; Zhao R; Song H
    Front Cell Infect Microbiol; 2024; 14():1336821. PubMed ID: 38357445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage therapeutics: from promises to practices and prospectives.
    Bhargava K; Nath G; Bhargava A; Aseri GK; Jain N
    Appl Microbiol Biotechnol; 2021 Dec; 105(24):9047-9067. PubMed ID: 34821965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists.
    Squires RA
    Vet Dermatol; 2021 Dec; 32(6):587-e158. PubMed ID: 33870572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective.
    Kaur G; Agarwal R; Sharma RK
    Food Environ Virol; 2021 Dec; 13(4):433-446. PubMed ID: 34120319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
    Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
    Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.